The company submitted an application for a seasonal flu vaccine it believes to be a key growth driver in the years ahead.
Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS Newswire / January 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today provided an ...
Editorial: Over the holiday period, the Guardian leader column is looking ahead at the themes of 2026. Today we examine how the White House’s war on vaccines has left the future of a key technology un ...
RFK Jr. canceled $500 million of funding for research on mRNA vaccine technology. Anadolu/Getty Images At a Sept. 4, 2025, hearing before the Senate Finance Committee, Health and Human Services ...
15don MSN
Moderna receives $54.3M investment for bird flu vaccine, covering axed federal mRNA contracts
Moderna announced Thursday it will receive up to $54.3 million from a global vaccine partnership to fund its ongoing research ...
Research on mRNA vaccines have been under fire in the post-pandemic age, but these immunotherapies are showing promise in the ...
The Department of Health and Human Services has defended cuts to vaccine research with statements that mislead on the safety of mRNA technology, despite an extensive history of testing. “After a ...
The success of mRNA technology and its potential uses in therapeutics and preventative medical treatment may create a new technology ecosystem, the Harvard Business Review reported April 18. As has ...
Morning Overview on MSN
Experimental mRNA therapy reverses immune-cell aging in mice
Researchers have used an experimental mRNA therapy to make old immune cells in mice behave as if they were young again, ...
Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving COVID-19 shots. There's a catch: The mRNA ...
A nurse reaches for a vial of Pfizer-BioNTech COVID-19 vaccine at a vaccine clinic in this March file photo. (Robyn Beck/AFP via Getty Images/TNS) Several states have effectively declared war on ...
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of an advanced animal mRNA vaccine platform to accelerate the development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results